Replies to post #508263 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Clearly patients will pay for any opportunity to extend their lives. In terms of affordability, maybe the price of the helmet comes down ...that kind of thing happens in economics, although I’m not sure where I read it?

Also, because Vax extends survival but is not a cure, this may in fact increase the addressable market for the helmet.

And don’t believe me. Listen to Dr Ashkan’s thoughts on the subject.

[LearningEveryTrade]

I can't wait for an Optune/DCVAX trial... it would be pretty easy to do, since Optune is an approved "device".
To add this on to what we believe is the new SOC, that would be a no-brainer.

I also, can't wait for a monotherapy trial. I believe the current SOC hurts the immune system, so, who knows how powerful the immune system can be !!